Nelson Hamerschlak
Overview
Explore the profile of Nelson Hamerschlak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
236
Citations
1827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hyppolito J, Arcuri L, Vicente A, Farnese V, Santucci R, Pfister V, et al.
Eur J Haematol
. 2025 Jan;
114(4):704-706.
PMID: 39887484
No abstract available.
2.
Rodrigues A, Fernandes J, Gregianin L, Nichele S, Trennepohl J, Muratori R, et al.
Bone Marrow Transplant
. 2025 Jan;
PMID: 39865157
Hematopoietic stem cell transplantation (HSCT) is an established treatment for selected patients with inborn errors of metabolism. In this first report from the PDWP-SBTMO, we included 105 patients transplanted between...
3.
Duarte F, Garcia Y, Hamerschlak N, Funke V, Moreira M, Aparecida Paz A, et al.
Transplant Cell Ther
. 2024 Dec;
31(2):79.e1-79.e9.
PMID: 39674548
This study analyzed recent changes in the utilization of allogeneic hematopoietic cell transplantation (HCT) for treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myeloproliferative diseases (MPDs) and the...
4.
Azevedo J, Godoy J, Souza C, Sielski M, Coa L, Barbosa Junior A, et al.
Einstein (Sao Paulo)
. 2024 Dec;
22:eRW0612.
PMID: 39661859
Natural Killer cells are immune leukocytes required for responses against tumor cells and virus-infected cells. In the last decade, natural killer cells have emerged as promising tools in cancer therapy,...
5.
da Silva D, Duarte B, de Oliveira Y, Piaia C, Aragao J, Chapchap E, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Dec;
PMID: 39643564
Background: T-cell acute lymphoblastic leukemia (T-ALL) remains understudied compared to B-cell ALL, especially in Latin America. Different biology and response to chemotherapy have been described. Methods: This retrospective multi-site cohort...
6.
Manfredini L, Conte E, Santos G, Leao E, Hamerschlak N
Einstein (Sao Paulo)
. 2024 Oct;
22:eAO0693.
PMID: 39417480
Background: Manfredini et al. demonstrate that the new rating protocol, EMOnco, can triage of cancer patients in acute care settings safely, considering their cancer type, stage and treatment histories and...
7.
Cesar B, Braga W, Hamerschlak N, Durao Junior M
BMC Nephrol
. 2024 Oct;
25(1):344.
PMID: 39390432
Kidney disease is a common complication of multiple myeloma (MM) and a risk factor for increased morbimortality. In this retrospective cohort study based on medical records, we analyzed the kidney...
8.
Kerbauy M, Rocha F, Arcuri L, Cunegundes P, Kerbauy L, Machado C, et al.
Haematologica
. 2024 Sep;
110(3):640-650.
PMID: 39279428
Post-transplant cyclophosphamide (PTCy) has contributed to the success of haploidentical hematopoietic stem cell transplantation (HSCT) and is also used in transplantation from matched donors. However, limited data on the immune...
9.
Chapchap E, Melo N, Martins D, Lee M, Hamerschlak N
Hematol Transfus Cell Ther
. 2024 Aug;
46 Suppl 6:S182-S192.
PMID: 39129098
Introduction: The scenario of adult patients with acute lymphoblastic leukemia treated in Brazil has not been well described yet. Methods: Four hundred patients diagnosed with acute lymphoblastic leukemia from 1981...
10.
Americo A, Silva C, Kerbauy M, Arcuri L, Ribeiro A, Hamerschlak N, et al.
Hematol Transfus Cell Ther
. 2024 Aug;
46 Suppl 6:S427-S430.
PMID: 39095316
No abstract available.